Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 9 Feb 23 EFFECT Notice of effectiveness
- 3 Feb 23 POS AM Prospectus update (post-effective amendment)
- 18 Nov 22 424B3 Prospectus supplement
- 17 Aug 22 424B3 Prospectus supplement
- 6 Jun 22 424B3 Prospectus supplement
- 13 May 22 424B3 Prospectus supplement
- 29 Apr 22 424B3 Prospectus supplement
- 27 Apr 22 EFFECT Notice of effectiveness
- 20 Apr 22 POS AM Prospectus update (post-effective amendment)
- 29 Dec 21 424B3 Prospectus supplement
- 16 Dec 21 EFFECT Notice of effectiveness
-
3 Dec 21 S-1 IPO registration
SABS similar filings
Filing view
External links
Exhibit 23.3
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the inclusion in this Registration Statement on Form S-1 and related prospectus of our reports dated June 17, 2021, with respect to the consolidated financial statements of SAB Biotherapeutics, Inc. and Subsidiaries (Company) as of December 31, 2020 and 2019 and for the two years then ended, and to the reference to us under the heading “Experts” in the prospectus, which is part of this Registration Statement.
/s/ Mayer Hoffman McCann P.C.
San Diego, California
December 3, 2021